Photoselective vaporization of the prostate for the treatment of benign prostatic hyperplasia: Initial clinical outcomes

To evaluate the efficacy and safety of photoselective vaporization of the prostate (PVP) for the treatment of benign prostatic hyperplasia (BPH), total 24 patients (mean age of 71.009.74 years) with BPH underwent PVP in our hospital by using Realton 100 W surgical green laser system. Prostate size, operation time, blood loss during operation, catheterization time and hospital stay were recorded. International prostate symptom score (I-PSS), maximum flow rate (Qmax), post void residual urine (PVR) were compared to the baseline. The results show that PVP is a safe and effective treatment for BPH, especially suitable for aged, high-risk or anticoagulant therapy patients. PVP has less bleeding during operation, shorter catheterization time and hospital stay. More follow-ups are needed to evaluate its long-term efficiency.